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Abstract
Purpose of Review The association between mental health, pain, and treatment-resistant hypertension is an important consider-
ation for treating physicians. We review and discuss the connection between conditions of anxiety, depression, and chronic pain
and their effect on uncontrolled hypertension.
Recent Findings There is significant co-occurrence of hypertension with anxiety, depression, and chronic pain which may lead to
undertreatment of hypertension and undertreatment of the underlying mental health disorder. The association between mental
health and hypertension is complex and is modulated by physiologic and environmental factors.
Summary Physicians treating patients with hypertension should be cognizant of the role anxiety, depression, and chronic pain
play in treatment efficacy and compliance. Patients undergoing treatment should be screened for mental health disorders at
treatment initiation and frequently thereafter to ensure optimal overall health and compliance.
Keywords Uncontrolled hypertension .Medication compliance . Anxiety . Pain . Depression
Introduction
There has been considerable interest in the link between hy-
pertension, anxiety, and pain in the recent literature given the
significant disease burden and associated cardiovascular mor-
tality. Approximately 45% of the adult US population live
with hypertension and about 76% of those patients continue
to be sub-optimally treated despite lifestyle and medication
modifications [1••]. In addition, psychological comorbidities
have been linked to worse cardiovascular outcomes [2–4].
With an estimated prevalence of 19.1% of the adult US pop-
ulation [5], anxiety has the potential to significantly worsen
hypertension and alter disease progression.
In addition to mental health, pain and perception of pain
has similarly been associated with elevated blood pressure.
We provide a review of the recent literature discussing
hypertension and its connection to pain and anxiety and how
it relates to diagnosis, treatment, prognosis, and overall quality
of life.
Anxiety and Hypertension
Approximately 45% adults in the USA live with a diagnosis of
hypertension [1••] and approximately 19% of the adult popu-
lation suffers from disorders of anxiety [5]. Given the high
prevalence of both diseases, it is important to understand the
relationship between anxiety and hypertension. Data from the
2005National AmbulatoryMedical Care Survey and National
Hospital Ambulatory Medical Care Survey showed that up to
32.5% of outpatients presenting for anxiety treatment had un-
recognized elevated blood pressure measurements, compared
to 24.6% of all ambulatory patient visits [6].
Relationship Between Anxiety
and Hypertension
The link between hypertension, anxiety, and stress can be evident
as soon as early adulthood. Sujatha et al. assessed the prevalence
of prehypertension in association with stress and anxiety in




1 Henry Ford Hospital, EmergencyMedicine, Detroit, MI 48202, USA
2 Wayne State University, Detroit, MI 48202, USA
https://doi.org/10.1007/s11906-020-01117-2
/ Published online: 10 November 2020
Current Hypertension Reports (2020) 22: 106
college-age patients. In a cohort of 323 patients, prehypertension
was highest among medical students (55.6%), more than their
engineering and art major peers. Medical students also had the
highest levels of anxiety (20.3%), while engineering students had
a higher prevalence of stress (58.9%). Furthermore,
prehypertension was 1.8 times more likely in students with anx-
iety and 1.4 times more likely with students with high stress [7].
In a different study assessing anxiety in older adults (mean age
69 years), hypertensive patients, especially thosewith a history of
stroke and depression, were more likely to develop anxiety, sug-
gesting that screening and early intervention for anxiety may be
beneficial in older adults with hypertension [8].
Acute stress has also been linked to elevated blood pressure.
Turkish researchers collected blood pressure values 1 day be-
fore an elective cholecystectomy from 90 participants [9]. Half
of the participants were randomly selected to be shown the
operating room the day before the procedure, while the rest
were not. The researchers found that patients who were shown
the operating room had lower blood pressure values compared
to those who did not see the operating rooms until the day of
surgery. The stress of the unknown played a role in increased
blood pressure values prior to the procedure; previewing the
operating room prior to surgery helped to alleviate stress which
in turn helped to lower blood pressure measurements [9].
The prevalence of hypertension in the general population is
a result of modifiable (environmental factors, diet, obesity,
sodium intake, and physical activity) and non-modifiable risk
factors (genetic predisposition) [10]. Whether anxiety predis-
poses an individual to develop hypertension remains contro-
versial. Recent studies show a high incidence of anxiety in
patients with treatment-resistant hypertension [11, 12•]. In ad-
dition, rates of anxiety are higher in hypertensive patients who
have poor adherence to medical therapy [13]. Lambert et al.
evaluated whether obesity and diabetes with concomitant anx-
iety made individuals more susceptible to the development of
hypertension. They found that stress from chronic anxiety
modulated a sympathetic firing pattern activating both sym-
pathetic nervous system and hypothalamic-pituitary-adrenal
axis in patients with metabolic syndrome resulting in elevated
blood pressure [14]. However, this study was limited by small
sample size, and long-term sequela was not explored. In con-
trast, the large-scale Norwegian HUNT study compared levels
of anxiety among 55,472 patients with their corresponding
blood pressures and found no association between anxiety
and hypertension [15]. Given the findings of the HUNT study,
the association between anxiety and hypertension is weak.
White Coat Hypertension
and Over-/Undertreatment
White coat hypertension (WCH), which is a transient elevation
in blood pressure measurements restricted to clinical settings,
has a prevalence of 13–35% [16]. Between 1 and 5% of pa-
tients with WCH progress to clinical hypertension [10]. White
coat hypertension may lead to overdiagnosis of hypertension
and increased use of antihypertensive therapy despite the lack
of association of WCH with cardiovascular disease and all-
cause mortality [10, 17]. Patients that perceived themselves as
hypertensive often reported a greater degree of anxiety in the
outpatient setting and showed a larger degree of WCH [17].
Nevertheless, Murata et al. [18] found that WCH was not as-
sociated with anxiety after controlling for confounding vari-
ables and that WCH in healthy normotensive elderly patients
could reflect a decrease in endothelial function rather than
anxiety.
Despite the challenges WCH presents, the American
College of Cardiology (ACC) and the American Heart
Association (AHA) recommend utilizing ambulatory blood
pressure monitoring (ABPM), supplemented with home blood
pressure measurements (HBPM), to more accurately delineate
hypertension fromWCH, better predict cardiovascular disease
risk, and guide therapy [10].
Effect of Anxiety on Circadian Rhythm
and Hypertension
Anxiety has a significant effect on quality of life, both physio-
logical through sympathetic arousal and circulating catechol-
amines and behavioral responses such as increased eating, alco-
hol consumption, or smoking. Anxiety may also play a role in
developing circadian abnormalities [2]. Özpelit et al. [2] found
that anxious patients were more likely to experience diurnal
hypertension, with a lack of blood pressure dip during the night
and elevated blood pressure readings in the morning.
Furthermore, hypertensive patients with disrupted circadian
rhythm were found to have increased circulating inflammatory
markers and decreased vagal modulation of blood pressure upon
awakening [19].
Depression and Hypertension
Several studies have shown an association between depres-
sion and hypertension. While the Norwegian HUNT study
did not find an association between anxiety and hypertension,
there was a positive relationship between depressive symp-
toms and multi-drug antihypertensive medication regimens.
This study suggested that poor antihypertensive treatment ad-
herence potentially leads to polypharmacy in patients with
depression [15]. Studies from Nigeria, Ghana, and Pakistan
have shown the prevalence of depression among hypertensive
patients to be between 26 and 42% [20, 21]. In a large Finland
study of 4450 patients, depression was found to be present in
14.1% of patients diagnosed with hypertension (as compared
to 8.7% of patients without hypertension) [22]. Depressed
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patients had 1.4 times higher likelihood of having hyperten-
sion, and reported stress similarly increased the likelihood of
hypertension by 1.4 times [21]. In a study assessing risk fac-
tors for developing depression in patients with hypertension,
Rantanen et al. [22] identified female gender, excess alcohol
use, elevated body mass index, smoking, and low physical
activity as risk factors.
The link between depression and increased rates of hyper-
tension has also been explored using physiological scales. Peng
et al. [23] found a significant relationship between depression,
arterial stiffness, and hypertension in a study conducted in
China. Patients had brachial-ankle pulse wave velocities
(baPWV)measured to determine arterial stiffness. Patients with
depressive symptoms were found to have increased baPWV
when controlling for confounding variables. They concluded
that the degree of depressive symptoms was independently
associated with arterial stiffness [23].
Antidepressant therapy is also independently associated
with elevated blood pressures. The National Study of
Adolescent to Adult Health (ADD Health) is a longitudinal
study that followed 20,745 teenagers to adulthood. The study,
which included 11,183 final participants, concluded that anti-
depressant use was associated with hypertension and that men
on antidepressants had a greater likelihood of having elevated
blood pressure versus men not taking antidepressants. There
was no association among women taking antidepressants and
having hypertension [24]. The study also found that use of
antidepressants led to an average increase of 1.6 mmHg dia-
stolic blood pressure levels without any increase in systolic
blood pressure levels. This study questions whether depres-
sion itself leads to elevated blood pressures or treatment of
depression causes elevation in blood pressure [24], a question
that remains unanswered in the current literature.
Effect of Psychiatric Illness on Perceptions of Blood
Pressure Control/Barriers to Treatment
Medication adherence to lower blood pressures to goal are
important in preventing development of cardiovascular and
end-organ complications which can become difficult with
multiple comorbidities including psychiatric illness. The
Framingham Heart Study examined risk factors for medica-
tion adherence and suggested that depressive symptoms may
act as a barrier to medication adherence, which exacerbates
cardiovascular disease risk factors, including hypertension, in
older adults [25•]. Additionally, in a retrospective cohort anal-
ysis of 431,591 patients, factors that included chronic mental
illness and adherence to psychiatric medications predicted ad-
herence to antihypertensive therapy [26].
Additionally, patients with chronic medical conditions
such as hypertension can develop negative emotions leading
to anxiety, stress, and depression and these patients exhibit a
higher likelihood of medication non-compliance [27].
Pain and Hypertension
In addition to psychiatric illness, hypertension has been shown
to be more prevalent in individuals with persistent pain as
compared to those in the general community [28].
Giummarra et al. [28] performed a registry-based study of
40,000 individuals reporting persistent non-cancer pain regis-
tered to the electronic Persistent Pain Outcomes Collaboration
(ePPOC) registry in Australia. Compared with the general and
primary care Australian population, hypertension was found
to be more prevalent in patients in the ePPOC cohort. When
adjusted for age, hypertension prevalence was 1.7 times more
prevalent in the ePPOC pain cohort [28]. Sub-analysis of the
ePPOC cohort did not find correlation between hypertension
and quality of life components of chronic pain severity such as
widespread pain, interference with daily living, or frequency
of pain catastrophizing [28].
Elevated blood pressure in the presence of acute or chronic
pain has been evaluated. Frequently, elevated blood pressures
in the Emergency Department (ED) are disregarded in the
setting of acute pain [29••]. Poon et al. [29••] evaluated the
relationship between ED blood pressure and follow up blood
pressure readings for 1 year after ED visit. After analyzing
data from 8150 patients, they found no evidence that high
blood pressure in the ED is attributable to pain. They also
found that patients with elevated BP in the ED, regardless of
chief complaint, including pain-related complaints, were asso-
ciated with elevated blood pressures after the ED visit [29••].
This highlights the need for follow-up and close blood pres-
sure monitoring and treatment after ED visits in patients with
elevated ED blood pressures.
Several studies have evaluated the physiological link be-
tween pain and hypertension [30–34]. These effects can be dis-
tinguished between individuals suffering acute or chronic pain.
In the acute pain response, a nociceptive stimulus activates the
sympathetic nervous system and the hypothalamic-pituitary-
adrenal axis which compounds the sympathetic response lead-
ing to adrenergic and cardiovascular responses directly elevating
blood pressure [35•].
Altered Pain Perception in the Hypertensive Patient
Elevated blood pressure has been associated with down-
regulation of the pain response, termed the hypertension-
hypoalgesia response [36]. There are two proposed mechanisms
for the hypertension-hypoalgesia response. The first is
baroreceptor-mediated reduction of cerebral arousal, with the
nucleus of the solitary tract proposed as a link between the vagus
nerve and spinal dorsal column [36]. This was described in an
animal model where rats showed decreased running to avoid
noxious stimuli with phenylephrine infusions rather than with
saline, and this effect was abolished with denervated barorecep-
tors [37]. In an alternative mechanism, opioid systems are
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theorized to contribute to the hypertension-hypoalgesia phe-
nomenon. Reduced pain sensitivity in hypertensive rats was
found to be pharmacologically reversible with opioid receptor
inhibitors [38]. Human studies have attempted to demonstrate
opioid system mechanisms without success [31, 32, 39].
Further work done by Guasti et al. has confirmed changes in
pain perception in patients with hypertension. Researchers ran-
domized known hypertensive patients to angiotensin converting
enzyme inhibitor therapy and compared hypoalgesic effects in
pain perception [40]. Untreated hypertensives showed reduced
perception to painful stimuli compared with normotensives [40].
This effect was found both with the ACE inhibitor and enalapril,
and with the angiotensin receptor blocker, losartan.
Chronic Pain and the Hypertension-Hypoalgesia
Response
The hypertension-hypoalgesia response is dysregulated in pa-
tients suffering from chronic pain. Chronic pain patients are
known to exhibit wind-up, or frequency-dependent increase in
afferent nociceptive fiber stimulation of spinal cord neurons
[41]. Chung et al. tested resting blood pressure and baroreflex
activity effect on wind-up in health controls as compared to
chronic pain patients. Their findings confirmed higher resting
systolic blood pressure and baroreceptor sensitivity to be as-
sociated with lower wind-up, and found this pathway was
altered in individuals with chronic pain [41]. Similar findings
were noted in the Tromso study [42]. This confirmed the link
between chronic pain and impaired cardiovascular regulation,
with chronic pain groups displaying lower heart rate variation
and lower baroreflex sensitivity than pain free controls [42].
Disrupted autonomic balance and decreased parasympathetic
tone is proposed by Tracy et al. [43] in meta-analytic work for
decreased heart rate variability in chronic pain patients. This
meta-analysis reviewed 26 studies on the subject of heart rate
variation and confirmed a moderate to large decrease in heart
rate variability [43]. Further work could be done to directly
connect these findings to the abolition of the hypertension-
hypoalgesia response seen in individuals with chronic pain.
The differences among patients experiencing acute versus
chronic pain may be due to diminished endogenous opioid
levels found in chronic pain patients [44]. Subsequent work
by Bruehl et al. [32] suggested an inverse relationship between
blood pressure and pain sensitivity in pain free subjects, and
found that this was not affected by opioid blockade administra-
tion. When low back pain subjects were included in the analy-
ses, the relationships between blood pressure and pain ratings
became positive rather than negative, consistent with suspected
dysregulation of cardiovascular and pain regulatory systems in
chronic pain [32]. Further work by Ring et al. [31] used a
double-blind placebo-controlled study to compare naltrexone
versus placebo on electrocutaneous pain. Hypertensive patients
experienced less pain than normotensive patients, but this effect
was not moderated by naltrexone [31]. Parallel work compared
effects of naltrexone and placebo on cold and ischemic pain in
patients newly diagnosed with essential hypertension
performing cold pressor and forearm ischemia tasks. This again
showed no moderation of pain and pressor responses with opi-
oid receptor blockade [45].
Non-Pharmacologic Treatment Strategies for Patients
with Uncontrolled Hypertension
Mental health disorders and chronic pain can lead to uncon-
trolled hypertension either due to medication non-compliance,
underdiagnosis, or lack of addressing hypertension in psychiat-
ric health visits. In addition to standard pharmacologic therapy,
patients with chronic mental health disorders or chronic pain
may benefit from non-traditional treatment strategies as adjuncts
to control blood pressure.
Regular exercise has shown to help pain scores which may
also be beneficial to improve blood pressure. In a small case-
control study evaluating 53 patients, Kruk and Nowicki tested
how regular exercise affects pain scores, anxiety, and depres-
sion in patients with treatment-resistant hypertension [46••].
Patients who underwent regular exercise saw a statistically
significant reduction in patient pain scores, depression scores,
and anxiety scores. While not powered or the primary aim of
the study, they also noted a correlation between reduction in
pain score and reduction in nocturnal systolic blood pressure,
heart rate, and anxiety levels [46••].
Wang et al. [47] evaluated the effect of mind sound reso-
nance technique (MSRT), a yoga-based relaxation technique,
on blood pressure, heart rate, and anxiety in individuals with
hypertension. Thirty patients attended two 30-min yoga ses-
sions on consecutive days, one for MSRT and one for supine
relaxation. Systolic and diastolic blood pressure measure-
ments, heart rate, and anxiety scores were measured before
and after the two sessions. Both groups saw a reduction in
heart rate and anxiety immediately afterwards, but patients
practicing MSRT experienced reduction in systolic and dia-
stolic blood pressures. Although limited, the study suggests
that regular yoga activity may be one modality to help reduce
both blood pressure and anxiety [47]. Further studies and
meta-analysis have also demonstrated blood pressure im-
provement with yoga, although its effects are modest [48].
Deep breathing and relaxation techniques have also shown
promise at reducing blood pressure. Jefferson studied the ef-
fects of combined diaphragmatic breathing with therapeutic
massage on blood pressure, stress, and anxiety in hypertensive
African American females [49]. After 1 week, there was sta-
tistically significant reduction in anxiety/pain surveys as well
as reduction in systolic and diastolic blood pressure measure-
ments [49].
Acupuncture therapy for hypertension has also been eval-
uated. The study by Li et al. revealed that patients undergoing
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auricular point therapy and relaxation techniques had a reduc-
tion in blood pressure and anxiety scores after 2 weeks of
intervention [50]. However, these effects do not appear to be
sustained. A Cochrane review evaluating the effects of acu-
puncture on blood pressure measurements showed no evi-
dence for sustained blood pressure lowering effect after eval-
uating data from 22 randomized control trials [51].
Conclusions
The connection between hypertension, mental health, and
chronic pain is complex and when present lead to treatment-
resistant hypertension, medication non-compliance, and worse
outcomes. Clinicians should be cognizant of the relationship
between mental health, pain, and hypertension when initiating
treatment (Fig. 1). A thorough history with particular attention
to anxiety, depressive symptoms, comorbid conditions, and
pain should be elucidated both at diagnosis and treatment ini-
tiation, and during follow-up visits for hypertension
management in the primary care setting. In addition to gold-
standard pharmacological therapy, non-traditional therapies at
reducing stress, anxiety, and depression should be considered
for treatment-resistant hypertension. Compliance and barriers
to medication compliance should also be addressed.
Addressing anxiety during these visits may also lead to
improved quality of life for patients [52]. Overall, studies
assessing the relationship between anxiety, depression, and
hypertension stress the importance of addressing anxiety and
other mental disorders in hypertension patients in an attempt
to guide medical therapy, enhance medication compliance,
and better control blood pressure [13].
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Fig. 1 Outline for the evaluation,
follow-up, and treatment of
elevated blood pressure in
patients with underlying pain or
psychiatric illness
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